Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Sunitinib-Induced Vascular Changes to Schedule Chemotherapy in Renal Cell Carcinoma Xenograft Tumors

In an attempt to develop better therapeutic approaches for metastatic renal cell carcinoma (RCC), the combination of the antiangiogenic drug sunitinib with gemcitabine was studied. Using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), we have previously determined that a sunitinib do...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hillman, Gilda Gali, Singh-Gupta, Vinita, Al-Bashir, Areen K, Zhang, Hao, Yunker, Christopher K, Patel, Amit D, Sethi, Seema, Abrams, Judith, Haacke, E Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2935633/
https://ncbi.nlm.nih.gov/pubmed/20885892
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados